Spinal Muscular Atrophy Trial, Recruiting NCT05663008 Sponsor: University of Dublin, Trinity College Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT05663008
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthy volunteers:

  • Be a similar age and gender to the patient groups in the study
  • Be physically able to take part in the experiment

For patients:

  • Have a diagnosis of ALS, PLS, PMA, SMA, Polio, or MS
  • Be able to understand and agree to take part in the study on your own

Who may not be able to join:

For healthy volunteers:

  • Have a history of any neuromuscular or neurological condition
  • Have a current or active mental health condition
  • Have a known reaction or allergy to recording equipment or the gels used during recordings

For patients:

  • Have a current or active mental health condition
  • Have a medical condition that causes severe nerve damage, such as poorly controlled diabetes
  • Have a known reaction or allergy to recording equipment or the gels used during recordings

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Orla Hardiman, BSc MB BCh BAO MD FRCPI FAAN, Academic Unit of Neurology, Trinity College Dublin, The University of Dublin

Phone: +353 1 896 4497

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Dublin, Trinity College
Registry
ClinicalTrials.gov
Start date
1 October 2015
Est. completion
30 January 2027

Where this trial is recruiting

🇮🇪 Ireland

Primary endpoints

EEG-EMG signatures for reliable and early distinction between healthy people and ALS patient subgroups (specifically ALS, PLS, PMA, and SMA).; EEG-EEG signatures for reliable and early distinction between healthy people and ALS patient subgroups (specially ALS, PLS, PMA, and SMA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov